Britain's Great Life Sciences Future - Genomics, Personalised Medicine and AI

Britain's Great Life Sciences Future - Genomics, Personalised Medicine and AI

The opportunities in life sciences have never been more exciting and the UK is playing a leading role. 

Genomics England is transforming the way patients are treated as individuals through the 100,000 Genomes Project and other genome mapping projects. Personalised targeted treatments including CAR-T and other cell and gene therapies are emerging. Meanwhile, AI technologies are revolutionising the way we discover new uses for drugs and improve the pharma supply chain with efficiencies and better analysis.

Given the coronavirus (COVID-19) situation, we are delighted to be bringing you the first-ever virtual 2020 PING Conference on Thursday 26 November 2020.

This one full-day virtual conference includes:

• An engaging, interactive programme with a high calibre of inspirational keynote speakers and presentations on key topics affecting the pharmaceuticals and life sciences industry
• High quality panel discussions and breakout sessions with individual speakers
• Networking opportunities with other attendees

PING is renowned for its personalised approach, giving you the opportunity to develop and cement relations with existing contacts and meet new people. The informative programme will translate into the online format in an interactive way. We are excited with the opportunities that this new format brings, and are looking forward to doing things a bit differently this year.

View the latest Conference synopsis.

By invitation only, join us on 26 November 2020 (rescheduled from 3 June 2020) to hear about Britain's exciting life sciences future.

The cost of this virtual online conference is £95 (plus VAT if applicable).

To request a place, please email the events team (Please note this is an invitation only event)

Who Will Be Speaking?

• Parker Moss - Chief Commercial and Partnership Officer, Genomics England
• Joanne Hackett - Chair, Pexxi and formerly Chief Commercial Officer, Genomics England
• Matthew Durdy - Chief Business Officer, Cell and Gene Therapy Catapult
• Karen Taylor and John Haughey - Head of Centre for Health Solutions and Global Life Sciences Consulting Leader, Deloitte
• Jackie Hunter - Board Director, Benevolent AI
• Nick Lench - Chief Scientific Officer, Congenica
• John McKinley - Executive Board Director, Avesthagen
• Yogesh Davé - Director, Cypress Quality Consultancy
• Bill Liao - General Partner, SOS Ventures
• Laura Towart - CEO, My Personal Therapeutics
• Jonathan O'Keeffe - Founder, Machine Medicine Technologies

View the latest Conference synopsis.

Follow us #PING20

Why Should I Attend?

PING has developed a strong reputation for top quality speakers and is a fantastic opportunity to learn, network and reflect on the changes that are impacting the pharma industry. You will come away with a greater understanding of what the future looks like for the industry as well as some very useful industry contacts. 

How Much Does It Cost to Attend?

The rate of this virtual online conference is £95 (plus VAT if applicable) (please note this is an invitation only event).

Don't miss out, email us today to book your space

Follow us #PING20